410 related articles for article (PubMed ID: 11463228)
21. Comparison of bcg strains for delayed hypersensitivity induction tested in vivo in guinea pigs and in vitro.
Smerák P; Průchová J; Sír Z
J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):435-44. PubMed ID: 6761395
[TBL] [Abstract][Full Text] [Related]
22. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
23. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions].
Klose F; Schallehn G
Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180
[No Abstract] [Full Text] [Related]
24. [The level and spectrum of antituberculosis antibodies in BCG-vaccinated mice and in mice and rabbits infected with a virulent mycobacterial culture].
Markov AN; Nikonenko BV; Chernousova LN; Levi DT; Dem'ianenko NV; Litvinov VI
Probl Tuberk; 1993; (1):43-4. PubMed ID: 8327439
[TBL] [Abstract][Full Text] [Related]
25. [BCG: symposium].
Takase Y; Kayaba K; Kobayashi T; Horai Z; Yokoi M
Kekkaku; 1970 Nov; 45(11):390-2. PubMed ID: 4924414
[No Abstract] [Full Text] [Related]
26. Comparative immunogenicity of BCG substrains for mice.
Júnior LP; Gontijo Filho PP
Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):311-6. PubMed ID: 394227
[TBL] [Abstract][Full Text] [Related]
27. A possible relationship between delayed hypersensitivity and cell-mediated immunity.
Salvin SB; Neta R
Am Rev Respir Dis; 1975 Apr; 111(4):373-7. PubMed ID: 47728
[No Abstract] [Full Text] [Related]
28. [Morphological study of tuberculin reaction to determine the body responsiveness in tuberculosis].
Diukanova MIa
Probl Tuberk; 2003; (3):45-8. PubMed ID: 12744065
[No Abstract] [Full Text] [Related]
29. Low doses of recombinant interleukin-2 enhance delayed type hypersensitivity to PPD in mice infected with Mycobacterium bovis-BCG and fed a diet supplemented with vitamin A acetate.
Ferraro F; Mattei M; Colizzi V
Z Erkr Atmungsorgane; 1988; 171(1):45-9. PubMed ID: 3057751
[TBL] [Abstract][Full Text] [Related]
30. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
31. [Immunity in tuberculosis: a model of cellular immunity].
Farga V
Rev Med Chil; 1982 May; 110(5):493-5. PubMed ID: 7163686
[No Abstract] [Full Text] [Related]
32. A long-lasting enhancing effect of anti-tuberculin antiserum on delayed-type hypersensitivity reaction in BCG-infected guinea pigs.
Mauch H; Hammer HJ; Kümel G
Immunobiology; 1980 Jan; 156(4-5):477-82. PubMed ID: 6989751
[TBL] [Abstract][Full Text] [Related]
33. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
Yamamoto K
Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
[No Abstract] [Full Text] [Related]
34. Modulation of the immune response by BCG: a review.
Murahata RI; Mitchell MS
Yale J Biol Med; 1976 Jul; 49(3):283-91. PubMed ID: 785826
[No Abstract] [Full Text] [Related]
35. Perspectives for BCG standardization.
Lévy FM; Mande R; Conge G; Fillastre C; Orssaud E
Bibl Tuberc; 1968; 24():63-190. PubMed ID: 4984263
[No Abstract] [Full Text] [Related]
36. [Study of a role of artificial mycobacterial particles in the realization of immunological processes in experimental animal tuberculosis].
Azaev MSh; Lebedev LR; Kuz'micheva GA; Tumanov IuV; Donchenko NA; Tat'kov SI; Nosareva OV; Il'ichev AA
Probl Tuberk Bolezn Legk; 2007; (2):38-42. PubMed ID: 17419334
[TBL] [Abstract][Full Text] [Related]
37. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
Nyabenda J; Pierre M; Keuterickx F; de Backer P
Dev Biol Stand; 1986; 58 ( Pt A)():43-52. PubMed ID: 3297875
[No Abstract] [Full Text] [Related]
38. Cell-mediated immunity in neonatal calves: delayed-type hypersensitivity and lymphocyte blastogenesis following immunization with a mycobacterial immunopotentiating glycolipid and tuberculoproteins of Mycobacterium bovis.
Woodard LF; Renshaw HW; Burger D
Am J Vet Res; 1978 Apr; 39(4):579-84. PubMed ID: 347995
[No Abstract] [Full Text] [Related]
39. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
Kawahara M; Matsuo K; Honda M
Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
[TBL] [Abstract][Full Text] [Related]
40. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
